Medical Care
Global Molecular Cancer Therapeutics Market Research Report 2025
- Mar 11, 25
- ID: 74818
- Pages: 86
- Figures: 82
- Views: 22
The global market for Molecular Cancer Therapeutics was valued at US$ 159 million in the year 2024 and is projected to reach a revised size of US$ 312 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Molecular cancer therapeutics focuses on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Cancer Therapeutics.
The Molecular Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Phoenix Molecular Designs
Prelude Therapeutics
Tempus
Bracco
iOmx Therapeutics
OncoDNA
Sapience Therapeutics
Caris Life Sciences
Hera Biolabs
CV6 Therapeutics
Carrick Therapeutics
Foundation Medicine
Cybrexa Therapeutics
Segment by Type
Monoclonal Antibodies
Small Molecule Inhibitors
Segment by Application
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Molecular cancer therapeutics focuses on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Cancer Therapeutics.
The Molecular Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Phoenix Molecular Designs
Prelude Therapeutics
Tempus
Bracco
iOmx Therapeutics
OncoDNA
Sapience Therapeutics
Caris Life Sciences
Hera Biolabs
CV6 Therapeutics
Carrick Therapeutics
Foundation Medicine
Cybrexa Therapeutics
Segment by Type
Monoclonal Antibodies
Small Molecule Inhibitors
Segment by Application
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecule Inhibitors
1.3 Market by Application
1.3.1 Global Molecular Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Leukemia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Cancer Therapeutics Market Perspective (2020-2031)
2.2 Global Molecular Cancer Therapeutics Growth Trends by Region
2.2.1 Global Molecular Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Cancer Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Molecular Cancer Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Molecular Cancer Therapeutics Market Dynamics
2.3.1 Molecular Cancer Therapeutics Industry Trends
2.3.2 Molecular Cancer Therapeutics Market Drivers
2.3.3 Molecular Cancer Therapeutics Market Challenges
2.3.4 Molecular Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Cancer Therapeutics Players by Revenue
3.1.1 Global Top Molecular Cancer Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Molecular Cancer Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Molecular Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Cancer Therapeutics Revenue
3.4 Global Molecular Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Molecular Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Cancer Therapeutics Revenue in 2024
3.5 Global Key Players of Molecular Cancer Therapeutics Head office and Area Served
3.6 Global Key Players of Molecular Cancer Therapeutics, Product and Application
3.7 Global Key Players of Molecular Cancer Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Cancer Therapeutics Breakdown Data by Type
4.1 Global Molecular Cancer Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Molecular Cancer Therapeutics Forecasted Market Size by Type (2026-2031)
5 Molecular Cancer Therapeutics Breakdown Data by Application
5.1 Global Molecular Cancer Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Molecular Cancer Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Cancer Therapeutics Market Size (2020-2031)
6.2 North America Molecular Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Cancer Therapeutics Market Size by Country (2020-2025)
6.4 North America Molecular Cancer Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Cancer Therapeutics Market Size (2020-2031)
7.2 Europe Molecular Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Cancer Therapeutics Market Size by Country (2020-2025)
7.4 Europe Molecular Cancer Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Cancer Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Molecular Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Cancer Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Cancer Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Cancer Therapeutics Market Size (2020-2031)
9.2 Latin America Molecular Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Cancer Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Molecular Cancer Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Cancer Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Molecular Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Cancer Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Cancer Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Phoenix Molecular Designs
11.1.1 Phoenix Molecular Designs Company Details
11.1.2 Phoenix Molecular Designs Business Overview
11.1.3 Phoenix Molecular Designs Molecular Cancer Therapeutics Introduction
11.1.4 Phoenix Molecular Designs Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.1.5 Phoenix Molecular Designs Recent Development
11.2 Prelude Therapeutics
11.2.1 Prelude Therapeutics Company Details
11.2.2 Prelude Therapeutics Business Overview
11.2.3 Prelude Therapeutics Molecular Cancer Therapeutics Introduction
11.2.4 Prelude Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.2.5 Prelude Therapeutics Recent Development
11.3 Tempus
11.3.1 Tempus Company Details
11.3.2 Tempus Business Overview
11.3.3 Tempus Molecular Cancer Therapeutics Introduction
11.3.4 Tempus Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.3.5 Tempus Recent Development
11.4 Bracco
11.4.1 Bracco Company Details
11.4.2 Bracco Business Overview
11.4.3 Bracco Molecular Cancer Therapeutics Introduction
11.4.4 Bracco Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.4.5 Bracco Recent Development
11.5 iOmx Therapeutics
11.5.1 iOmx Therapeutics Company Details
11.5.2 iOmx Therapeutics Business Overview
11.5.3 iOmx Therapeutics Molecular Cancer Therapeutics Introduction
11.5.4 iOmx Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.5.5 iOmx Therapeutics Recent Development
11.6 OncoDNA
11.6.1 OncoDNA Company Details
11.6.2 OncoDNA Business Overview
11.6.3 OncoDNA Molecular Cancer Therapeutics Introduction
11.6.4 OncoDNA Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.6.5 OncoDNA Recent Development
11.7 Sapience Therapeutics
11.7.1 Sapience Therapeutics Company Details
11.7.2 Sapience Therapeutics Business Overview
11.7.3 Sapience Therapeutics Molecular Cancer Therapeutics Introduction
11.7.4 Sapience Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.7.5 Sapience Therapeutics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Details
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Molecular Cancer Therapeutics Introduction
11.8.4 Caris Life Sciences Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.8.5 Caris Life Sciences Recent Development
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Details
11.9.2 Hera Biolabs Business Overview
11.9.3 Hera Biolabs Molecular Cancer Therapeutics Introduction
11.9.4 Hera Biolabs Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.9.5 Hera Biolabs Recent Development
11.10 CV6 Therapeutics
11.10.1 CV6 Therapeutics Company Details
11.10.2 CV6 Therapeutics Business Overview
11.10.3 CV6 Therapeutics Molecular Cancer Therapeutics Introduction
11.10.4 CV6 Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.10.5 CV6 Therapeutics Recent Development
11.11 Carrick Therapeutics
11.11.1 Carrick Therapeutics Company Details
11.11.2 Carrick Therapeutics Business Overview
11.11.3 Carrick Therapeutics Molecular Cancer Therapeutics Introduction
11.11.4 Carrick Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.11.5 Carrick Therapeutics Recent Development
11.12 Foundation Medicine
11.12.1 Foundation Medicine Company Details
11.12.2 Foundation Medicine Business Overview
11.12.3 Foundation Medicine Molecular Cancer Therapeutics Introduction
11.12.4 Foundation Medicine Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.12.5 Foundation Medicine Recent Development
11.13 Cybrexa Therapeutics
11.13.1 Cybrexa Therapeutics Company Details
11.13.2 Cybrexa Therapeutics Business Overview
11.13.3 Cybrexa Therapeutics Molecular Cancer Therapeutics Introduction
11.13.4 Cybrexa Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.13.5 Cybrexa Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecule Inhibitors
1.3 Market by Application
1.3.1 Global Molecular Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Leukemia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Cancer Therapeutics Market Perspective (2020-2031)
2.2 Global Molecular Cancer Therapeutics Growth Trends by Region
2.2.1 Global Molecular Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Cancer Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Molecular Cancer Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Molecular Cancer Therapeutics Market Dynamics
2.3.1 Molecular Cancer Therapeutics Industry Trends
2.3.2 Molecular Cancer Therapeutics Market Drivers
2.3.3 Molecular Cancer Therapeutics Market Challenges
2.3.4 Molecular Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Cancer Therapeutics Players by Revenue
3.1.1 Global Top Molecular Cancer Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Molecular Cancer Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Molecular Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Cancer Therapeutics Revenue
3.4 Global Molecular Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Molecular Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Cancer Therapeutics Revenue in 2024
3.5 Global Key Players of Molecular Cancer Therapeutics Head office and Area Served
3.6 Global Key Players of Molecular Cancer Therapeutics, Product and Application
3.7 Global Key Players of Molecular Cancer Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Cancer Therapeutics Breakdown Data by Type
4.1 Global Molecular Cancer Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Molecular Cancer Therapeutics Forecasted Market Size by Type (2026-2031)
5 Molecular Cancer Therapeutics Breakdown Data by Application
5.1 Global Molecular Cancer Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Molecular Cancer Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Cancer Therapeutics Market Size (2020-2031)
6.2 North America Molecular Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Cancer Therapeutics Market Size by Country (2020-2025)
6.4 North America Molecular Cancer Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Cancer Therapeutics Market Size (2020-2031)
7.2 Europe Molecular Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Cancer Therapeutics Market Size by Country (2020-2025)
7.4 Europe Molecular Cancer Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Cancer Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Molecular Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Cancer Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Cancer Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Cancer Therapeutics Market Size (2020-2031)
9.2 Latin America Molecular Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Cancer Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Molecular Cancer Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Cancer Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Molecular Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Cancer Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Cancer Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Phoenix Molecular Designs
11.1.1 Phoenix Molecular Designs Company Details
11.1.2 Phoenix Molecular Designs Business Overview
11.1.3 Phoenix Molecular Designs Molecular Cancer Therapeutics Introduction
11.1.4 Phoenix Molecular Designs Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.1.5 Phoenix Molecular Designs Recent Development
11.2 Prelude Therapeutics
11.2.1 Prelude Therapeutics Company Details
11.2.2 Prelude Therapeutics Business Overview
11.2.3 Prelude Therapeutics Molecular Cancer Therapeutics Introduction
11.2.4 Prelude Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.2.5 Prelude Therapeutics Recent Development
11.3 Tempus
11.3.1 Tempus Company Details
11.3.2 Tempus Business Overview
11.3.3 Tempus Molecular Cancer Therapeutics Introduction
11.3.4 Tempus Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.3.5 Tempus Recent Development
11.4 Bracco
11.4.1 Bracco Company Details
11.4.2 Bracco Business Overview
11.4.3 Bracco Molecular Cancer Therapeutics Introduction
11.4.4 Bracco Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.4.5 Bracco Recent Development
11.5 iOmx Therapeutics
11.5.1 iOmx Therapeutics Company Details
11.5.2 iOmx Therapeutics Business Overview
11.5.3 iOmx Therapeutics Molecular Cancer Therapeutics Introduction
11.5.4 iOmx Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.5.5 iOmx Therapeutics Recent Development
11.6 OncoDNA
11.6.1 OncoDNA Company Details
11.6.2 OncoDNA Business Overview
11.6.3 OncoDNA Molecular Cancer Therapeutics Introduction
11.6.4 OncoDNA Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.6.5 OncoDNA Recent Development
11.7 Sapience Therapeutics
11.7.1 Sapience Therapeutics Company Details
11.7.2 Sapience Therapeutics Business Overview
11.7.3 Sapience Therapeutics Molecular Cancer Therapeutics Introduction
11.7.4 Sapience Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.7.5 Sapience Therapeutics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Details
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Molecular Cancer Therapeutics Introduction
11.8.4 Caris Life Sciences Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.8.5 Caris Life Sciences Recent Development
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Details
11.9.2 Hera Biolabs Business Overview
11.9.3 Hera Biolabs Molecular Cancer Therapeutics Introduction
11.9.4 Hera Biolabs Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.9.5 Hera Biolabs Recent Development
11.10 CV6 Therapeutics
11.10.1 CV6 Therapeutics Company Details
11.10.2 CV6 Therapeutics Business Overview
11.10.3 CV6 Therapeutics Molecular Cancer Therapeutics Introduction
11.10.4 CV6 Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.10.5 CV6 Therapeutics Recent Development
11.11 Carrick Therapeutics
11.11.1 Carrick Therapeutics Company Details
11.11.2 Carrick Therapeutics Business Overview
11.11.3 Carrick Therapeutics Molecular Cancer Therapeutics Introduction
11.11.4 Carrick Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.11.5 Carrick Therapeutics Recent Development
11.12 Foundation Medicine
11.12.1 Foundation Medicine Company Details
11.12.2 Foundation Medicine Business Overview
11.12.3 Foundation Medicine Molecular Cancer Therapeutics Introduction
11.12.4 Foundation Medicine Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.12.5 Foundation Medicine Recent Development
11.13 Cybrexa Therapeutics
11.13.1 Cybrexa Therapeutics Company Details
11.13.2 Cybrexa Therapeutics Business Overview
11.13.3 Cybrexa Therapeutics Molecular Cancer Therapeutics Introduction
11.13.4 Cybrexa Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025)
11.13.5 Cybrexa Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Molecular Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small Molecule Inhibitors
Table 4. Global Molecular Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Molecular Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Molecular Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Molecular Cancer Therapeutics Market Share by Region (2020-2025)
Table 8. Global Molecular Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Molecular Cancer Therapeutics Market Share by Region (2026-2031)
Table 10. Molecular Cancer Therapeutics Market Trends
Table 11. Molecular Cancer Therapeutics Market Drivers
Table 12. Molecular Cancer Therapeutics Market Challenges
Table 13. Molecular Cancer Therapeutics Market Restraints
Table 14. Global Molecular Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Molecular Cancer Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Molecular Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Cancer Therapeutics as of 2024)
Table 17. Ranking of Global Top Molecular Cancer Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Molecular Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Molecular Cancer Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Molecular Cancer Therapeutics, Product and Application
Table 21. Global Key Players of Molecular Cancer Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Molecular Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Molecular Cancer Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Molecular Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Molecular Cancer Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Molecular Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Molecular Cancer Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Molecular Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Molecular Cancer Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Molecular Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Molecular Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Molecular Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Molecular Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Molecular Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Molecular Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Molecular Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Molecular Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Molecular Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Molecular Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Molecular Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Molecular Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Molecular Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Molecular Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Molecular Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Phoenix Molecular Designs Company Details
Table 47. Phoenix Molecular Designs Business Overview
Table 48. Phoenix Molecular Designs Molecular Cancer Therapeutics Product
Table 49. Phoenix Molecular Designs Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Phoenix Molecular Designs Recent Development
Table 51. Prelude Therapeutics Company Details
Table 52. Prelude Therapeutics Business Overview
Table 53. Prelude Therapeutics Molecular Cancer Therapeutics Product
Table 54. Prelude Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Prelude Therapeutics Recent Development
Table 56. Tempus Company Details
Table 57. Tempus Business Overview
Table 58. Tempus Molecular Cancer Therapeutics Product
Table 59. Tempus Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Tempus Recent Development
Table 61. Bracco Company Details
Table 62. Bracco Business Overview
Table 63. Bracco Molecular Cancer Therapeutics Product
Table 64. Bracco Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Bracco Recent Development
Table 66. iOmx Therapeutics Company Details
Table 67. iOmx Therapeutics Business Overview
Table 68. iOmx Therapeutics Molecular Cancer Therapeutics Product
Table 69. iOmx Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 70. iOmx Therapeutics Recent Development
Table 71. OncoDNA Company Details
Table 72. OncoDNA Business Overview
Table 73. OncoDNA Molecular Cancer Therapeutics Product
Table 74. OncoDNA Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 75. OncoDNA Recent Development
Table 76. Sapience Therapeutics Company Details
Table 77. Sapience Therapeutics Business Overview
Table 78. Sapience Therapeutics Molecular Cancer Therapeutics Product
Table 79. Sapience Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Sapience Therapeutics Recent Development
Table 81. Caris Life Sciences Company Details
Table 82. Caris Life Sciences Business Overview
Table 83. Caris Life Sciences Molecular Cancer Therapeutics Product
Table 84. Caris Life Sciences Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Caris Life Sciences Recent Development
Table 86. Hera Biolabs Company Details
Table 87. Hera Biolabs Business Overview
Table 88. Hera Biolabs Molecular Cancer Therapeutics Product
Table 89. Hera Biolabs Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Hera Biolabs Recent Development
Table 91. CV6 Therapeutics Company Details
Table 92. CV6 Therapeutics Business Overview
Table 93. CV6 Therapeutics Molecular Cancer Therapeutics Product
Table 94. CV6 Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 95. CV6 Therapeutics Recent Development
Table 96. Carrick Therapeutics Company Details
Table 97. Carrick Therapeutics Business Overview
Table 98. Carrick Therapeutics Molecular Cancer Therapeutics Product
Table 99. Carrick Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Carrick Therapeutics Recent Development
Table 101. Foundation Medicine Company Details
Table 102. Foundation Medicine Business Overview
Table 103. Foundation Medicine Molecular Cancer Therapeutics Product
Table 104. Foundation Medicine Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Foundation Medicine Recent Development
Table 106. Cybrexa Therapeutics Company Details
Table 107. Cybrexa Therapeutics Business Overview
Table 108. Cybrexa Therapeutics Molecular Cancer Therapeutics Product
Table 109. Cybrexa Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 110. Cybrexa Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Molecular Cancer Therapeutics Picture
Figure 2. Global Molecular Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Cancer Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Small Molecule Inhibitors Features
Figure 6. Global Molecular Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Molecular Cancer Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Lung Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Leukemia Case Studies
Figure 12. Others Case Studies
Figure 13. Molecular Cancer Therapeutics Report Years Considered
Figure 14. Global Molecular Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Molecular Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Molecular Cancer Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Molecular Cancer Therapeutics Market Share by Players in 2024
Figure 18. Global Top Molecular Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Cancer Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Molecular Cancer Therapeutics Revenue in 2024
Figure 20. North America Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Molecular Cancer Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Molecular Cancer Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Molecular Cancer Therapeutics Market Share by Region (2020-2031)
Figure 34. China Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Molecular Cancer Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Molecular Cancer Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Phoenix Molecular Designs Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 50. Prelude Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 51. Tempus Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 52. Bracco Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 53. iOmx Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 54. OncoDNA Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 55. Sapience Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 56. Caris Life Sciences Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 57. Hera Biolabs Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 58. CV6 Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 59. Carrick Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 60. Foundation Medicine Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 61. Cybrexa Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Molecular Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small Molecule Inhibitors
Table 4. Global Molecular Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Molecular Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Molecular Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Molecular Cancer Therapeutics Market Share by Region (2020-2025)
Table 8. Global Molecular Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Molecular Cancer Therapeutics Market Share by Region (2026-2031)
Table 10. Molecular Cancer Therapeutics Market Trends
Table 11. Molecular Cancer Therapeutics Market Drivers
Table 12. Molecular Cancer Therapeutics Market Challenges
Table 13. Molecular Cancer Therapeutics Market Restraints
Table 14. Global Molecular Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Molecular Cancer Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Molecular Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Cancer Therapeutics as of 2024)
Table 17. Ranking of Global Top Molecular Cancer Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Molecular Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Molecular Cancer Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Molecular Cancer Therapeutics, Product and Application
Table 21. Global Key Players of Molecular Cancer Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Molecular Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Molecular Cancer Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Molecular Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Molecular Cancer Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Molecular Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Molecular Cancer Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Molecular Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Molecular Cancer Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Molecular Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Molecular Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Molecular Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Molecular Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Molecular Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Molecular Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Molecular Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Molecular Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Molecular Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Molecular Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Molecular Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Molecular Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Molecular Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Molecular Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Molecular Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Phoenix Molecular Designs Company Details
Table 47. Phoenix Molecular Designs Business Overview
Table 48. Phoenix Molecular Designs Molecular Cancer Therapeutics Product
Table 49. Phoenix Molecular Designs Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Phoenix Molecular Designs Recent Development
Table 51. Prelude Therapeutics Company Details
Table 52. Prelude Therapeutics Business Overview
Table 53. Prelude Therapeutics Molecular Cancer Therapeutics Product
Table 54. Prelude Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Prelude Therapeutics Recent Development
Table 56. Tempus Company Details
Table 57. Tempus Business Overview
Table 58. Tempus Molecular Cancer Therapeutics Product
Table 59. Tempus Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Tempus Recent Development
Table 61. Bracco Company Details
Table 62. Bracco Business Overview
Table 63. Bracco Molecular Cancer Therapeutics Product
Table 64. Bracco Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Bracco Recent Development
Table 66. iOmx Therapeutics Company Details
Table 67. iOmx Therapeutics Business Overview
Table 68. iOmx Therapeutics Molecular Cancer Therapeutics Product
Table 69. iOmx Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 70. iOmx Therapeutics Recent Development
Table 71. OncoDNA Company Details
Table 72. OncoDNA Business Overview
Table 73. OncoDNA Molecular Cancer Therapeutics Product
Table 74. OncoDNA Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 75. OncoDNA Recent Development
Table 76. Sapience Therapeutics Company Details
Table 77. Sapience Therapeutics Business Overview
Table 78. Sapience Therapeutics Molecular Cancer Therapeutics Product
Table 79. Sapience Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Sapience Therapeutics Recent Development
Table 81. Caris Life Sciences Company Details
Table 82. Caris Life Sciences Business Overview
Table 83. Caris Life Sciences Molecular Cancer Therapeutics Product
Table 84. Caris Life Sciences Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Caris Life Sciences Recent Development
Table 86. Hera Biolabs Company Details
Table 87. Hera Biolabs Business Overview
Table 88. Hera Biolabs Molecular Cancer Therapeutics Product
Table 89. Hera Biolabs Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Hera Biolabs Recent Development
Table 91. CV6 Therapeutics Company Details
Table 92. CV6 Therapeutics Business Overview
Table 93. CV6 Therapeutics Molecular Cancer Therapeutics Product
Table 94. CV6 Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 95. CV6 Therapeutics Recent Development
Table 96. Carrick Therapeutics Company Details
Table 97. Carrick Therapeutics Business Overview
Table 98. Carrick Therapeutics Molecular Cancer Therapeutics Product
Table 99. Carrick Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Carrick Therapeutics Recent Development
Table 101. Foundation Medicine Company Details
Table 102. Foundation Medicine Business Overview
Table 103. Foundation Medicine Molecular Cancer Therapeutics Product
Table 104. Foundation Medicine Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Foundation Medicine Recent Development
Table 106. Cybrexa Therapeutics Company Details
Table 107. Cybrexa Therapeutics Business Overview
Table 108. Cybrexa Therapeutics Molecular Cancer Therapeutics Product
Table 109. Cybrexa Therapeutics Revenue in Molecular Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 110. Cybrexa Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Molecular Cancer Therapeutics Picture
Figure 2. Global Molecular Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Cancer Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Small Molecule Inhibitors Features
Figure 6. Global Molecular Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Molecular Cancer Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Lung Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Leukemia Case Studies
Figure 12. Others Case Studies
Figure 13. Molecular Cancer Therapeutics Report Years Considered
Figure 14. Global Molecular Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Molecular Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Molecular Cancer Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Molecular Cancer Therapeutics Market Share by Players in 2024
Figure 18. Global Top Molecular Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Cancer Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Molecular Cancer Therapeutics Revenue in 2024
Figure 20. North America Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Molecular Cancer Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Molecular Cancer Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Molecular Cancer Therapeutics Market Share by Region (2020-2031)
Figure 34. China Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Molecular Cancer Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Molecular Cancer Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Molecular Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Phoenix Molecular Designs Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 50. Prelude Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 51. Tempus Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 52. Bracco Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 53. iOmx Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 54. OncoDNA Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 55. Sapience Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 56. Caris Life Sciences Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 57. Hera Biolabs Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 58. CV6 Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 59. Carrick Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 60. Foundation Medicine Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 61. Cybrexa Therapeutics Revenue Growth Rate in Molecular Cancer Therapeutics Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232